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Mycoplasmas are the smallest known free-living microorganisms. Members of this 
genus cause disease  in plants, rodents, fowl,  and domestic animals (1  4).  These or- 
ganisms are also part of the normal flora of man, and at least one species,  Mycoplasma 
pneumoniae, is a proven pathogen for humans. The role of other species of mycoplasma 
in diseases of man has yet to be established. A voluminous literature has appeared per- 
taining to both humoral and cellular aspects of host  defense  with  regard  to  other 
microbes. Thus, numerous in vitro studies have been carried out of interactions be- 
tween bacteria and various types of phagocytic cells, but few such investigations have 
dealt with mycoplasma. Among the latter are morphological observations on the inter- 
action in vitro between various types of human cells with M. gallisepticum and M. 
neurolyticum (5, 6), and a very recent morphological study of ingestion of M. pulmonis 
by cultured mouse macrophages (7). 
This report deals with the interaction between human or rabbit polymorpho- 
nuclear leukocytes and M. hominis or arthritidis.  We have examined the ability 
of  the  leukocytes to  sequester  and kill mycoplasma,  to  mount a  number of 
metabolic responses known to occur during phagocytosis, and the effect of myco- 
plasma on the leukocytes' capability to kill Escherichia coll. 
Materials and Methods 
Granulocytes.--Rabbit granulocytes were collected from sterile peritoneal  exudates pro- 
duced by intraperitoneal  injection  of 0.1%  glycogen in normal saline. Differential counts 
showed that  the  cell suspensions contained  95%  or  more polymorphonuclear leukocytes. 
Human peripheral blood leukocytes were prepared from heparinized blood obtained by veni- 
puncture.  After mixing the blood with  one-fifth vol 6%  dextran  75  (Travenol Lab.  Inc., 
Morton Grove, Ill.), the erythrocytes were allowed to sediment by stationary incubation at 
37°C and the  leukocyte-rich plasma was then harvested.  Differential counts of these cells 
showed that 60-70% were polymorphonuclear leukocytes. The rabbit or human leukocytes 
were sedimented by centrifugation at 50 g for 10 min, washed, and resuspended in Eagle's 
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minimal essential medium  (MEM) I  or  medium  199  (Grand  Island  Biological Co.,  Grand 
Island, N.Y.)  at the desired concentration. Concentrated homogenates of granulocytes were 
prepared  in  distilled water using a  motor-driven teflon pestle.  The homogenates were then 
diluted to the desired concentration in MEM or medium 199. 
C~dture and Incubation  Procedures.-- 
Mycoplasmas  (pleuropneumonia-like  organisms  [PPLO]):  Mycoplasmas  were  grown  and 
maintained in broth or agar media. The broth contained 70% PPLO broth  (Difco Labora- 
tories, Inc., Detroit,  Mich.),  20% unheated horse serum,  10% yeast extract, 0.5% arginine 
hydrochloride, and  1000  units of penicillin/ml. Agar plates contained the  above  plus  1% 
Bacto-agar  (Difco Lab.).  M.  hominis  and M.  arthritidis strains grown overnight in  broth 
medium were sedimented by centrifugation at 10,000 g for 15 rain, washed, and resuspended in 
broth medium or MEM.  Species-specific  antisera directed at the mycoplasma used in these 
experiments were prepared by serial inoculation of rabbits with whole, heat-killed organisms 
emulsified in Freund's complete adjuvant. Specificity of the sera was determined by growth- 
inhibition tests  (8)  against homologous  and heterologous mycoplasma species.  Incubation 
mixtures consisted of mycoplasma at various concentrations of viable organisms,  4  X  107 
granulocytes/ml  or  comparable  concentrations  of  granulocyte  homogenate,  type- 
specific antiserum,  or normal rabbit serum in a  final concentration of  1/200,  all in a  total 
volume of 5 ml of MEM  or medium 199. Incubation was carried out in a  rotary shaker at 
37°C. Viability of the mycoplasmas was determined in duplicate Miquots of incubation mix- 
tures taken at various time intervals, serially diluted in PPLO  broth, and plated on  agar. 
Colony-forming units were enumerated after incubation of these plates at 37°C  for at least 
72 hr when the colonies could be seen without magnification..~diquots of some mycoplasma 
suspensions were also counted directly in a hemacytometer using a phase-contrast microscope. 
Labeling of PPLO Lipids with Palmitate-l-14C.-- 
M. hominis:  Lipids of M. hominis were labeled during growth overnight with palmitate-1- 
14C  (2.5  #Ci;  specific activity 55 mCi/mmole, Amersham-Searle Corp., Arlington Heights, 
Ill.)  complexed  to  bovine  serum  albumin  (9).  Lipids  of  suspensions consisting of  PPLO 
alone or with leukocytes were extracted by the method of Bligh and Dyer (10).  Total  radio- 
activity of the  lipid  extracts  and  the  distribution  of  the radioactivity  among major  lipid 
fractions, separated by thin-layer chromatography, were determined as previously described 
(11). 
E. coli:  The K-12 strain of E. coli was grown and maintained in heart infusion broth or on 
agar  slants.  Phagocytosis  experiments were  performed  with 4-hr  cultures  of E.  coli  sedi- 
mented by centrifugation at 3000 g, washed, and resuspended in MEM at the desired concen- 
tration before addition to incubation mixtures with granulocytes and mycoplasmas  as indi- 
cated. At intervals, duplicate aliquots of the bacterial suspensions were taken, diluted in heart 
infusion broth, and 0.1  ml of each dilution was incorporated into pour plates. Colonies were 
enumerated after incubation at 37°C overnight. 
Glucose-l-14C  metabolism:  Hexose  monophosphate  shunt  activity of  the  leukocytes  was 
measured by the conversion of glucose-l-14C  to  14CO2. Suspensions of leukocytes  (2  X  107 
cells) in MEM were placed in 10 ml Erlenmeyer flasks that contained 0.1 ml of  fresh frozen 
rabbit serum, 0.075 #Ci of giucose-l-14C  (260 #Ci/mg), PPLO in the concentrations indicated, 
and/or 0.1 ml of polystyrene particles  (1.1 #  diameter, 3.6  X  109 particles,  Dow  Chemical 
Company,  Midland,  Mich.)  in physiological saline. The  total volume of 0.5  mI  contained 
glucose in a final concentration of 80 mg per cent. Evolved 14CO2 was collected in polyethylene 
cups suspended from rubber stoppers  (Kontes Glass Co., Vineland, N.J.).  At  the indicated 
1 Abbreviations used in paper:  MEM,  Eagle's minimal essential medium; PPLO,  pleuro- 
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time intervals the reaction was stopped by injecting 0.2 ml of 10 N I-I2SO4 through the rubber 
stopper into the main chamber. Hyamine (0.4 ml) was added to the collection cups and incu- 
bation at 37°C was continued for 1 hr. At this time the cups were removed, placed in counting 
vials,  and  shaken  well with  12  ml of  toluene-BBOT  (2,5-bis-2-(5-tert-butylbenzoxazolyl)- 
thiophene, Packard Instrument Co., Downers Grove, IlL) scintillation mixture. Counting in 
a  Packard  liquid scintillation spectrometer was  carried  out immediately after addition  of 
scintillation mixture and cooling of the vials. Under these circumstances quenching was mini- 
mal. Radioactivity of portions of gIucose-l-14C was determined also in the presence of hyamine 
and thus provided an internal standard.  In some experiments, as indicated in the text, 0.075 
#Ci of glucose-6-14C was used in place of glucose-l-14C. 
Determination of the Conversion of Zysolecithin-3~P to Lecithin by Granulocytes.--This  pro- 
eedure has  been  described in detail elsewhere  (12-15).  In brief: Biosynthetically  prepared 
lecithin-~P was degraded to lysolecithin-32P by treatment with snake venom phospholipase 
u~  109  p.- 
~ 
108 
8  ~o  7  I  [  [ 
0  60  120 
MINUTES 
Fro. 1.  Viability of M. hominis  (PPLO)  incubated  with or without rabbit granulocytes 
and specific antiserum. Individual points represent the mean of duplicate viable counts deter- 
mined on aliquots taken at the indicated  times of incubation.  The open symbols represent 
allquots of the whole suspension and  the closed symbols aliquots of supernatant  fluids pre- 
pared by centrifugation of the suspension at 50 g for 10 rain. Incubation mixtures were pre- 
pared  as described in Materials and  Methods. 
A2. The labeled lysolecithin was complexed to bovine serum albumin (4 g/100 ml) in Hanks' 
solution (14). Incubation mixtures contained 5 X  10 ~ rabbit granulocytes in Hanks' solution, 
0.1 ml of lysolecithin-32P-albumin solution, approximately 5 X  10  ~ PPLO (as determined  by 
viable count) in 0.2 ml of growth medium or medium 199, and 0.1 ml of polystyrene particles 
suspended in physiological saline, all in a total volume of 0.5 ml. Mixtures devoid of PPLO or 
polystyrene particles were supplemented with the appropriate medium alone. The concentra- 
tion of lysolecithin in the final volume of 0.5 mI of each incubation mixture in different experi- 
ments ranged from 20 to 50 nmoles. Conversion of lysolecithin to lecithin was determined by 
radiochemical assay,  separating  the labeled compounds in lipid extracts of the incubation 
mixtures by thin-layer chromatography as previously described (12-15). 
RESULTS 
Effects of Human or Rabbit Granulocytes Incubated with PPLO on Viability of 
the Microorganisms.--In  marked  contrast  to rapid  killing of E.  coli and  other 
bacteria by rabbit  granulocytes in vitro, the viability of  M. hominis incubated 
under similar conditions was unaffected by the presence  of granulocytes (Fig. 1). 1420  POLYMORPItONUCLEAR  LEUKOCYTES  AND  I~YCOPLAS3IA 
Colony counts of aliquots taken over a  2-hr period  were virtually the same in 
suspensions of PPLO alone, in suspensions of PPLO and  granulocytes, and in 
the  supernatant  fluids obtained  after  the leukoeytes had been sedimented  by 
centrifugation.  Addition  of  antiserum  directed  at  mycoplasma  also  had  no 
effect on viability. 
When the ratio of PPLO to leukocytes was varied from 1 to 100, no decreased 
viability was observed at any concentration.  Fig.  2 shows such an experiment 
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FIG. 2.  Viability of M. hominis (PPLO) incubated with human peripheral blood leukocytes 
in the presence of antiserum  at varying  ratios  of organisms to cells. The experiment was 
carried out as described in legend of Fig. 1. 
carried out with human leukocytes. Similar results were obtained in experiments 
with  rabbit  granulocytes.  Moreover,  at  none  of  the  three  concentrations 
examined was there evidence of adherence of the mycoplasma to the phagocytes, 
since medium  after  sedimentation  of the  granulocytes and whole suspensions 
contained  comparable  numbers  of viable  organisms  (Fig.  3).  Thus,  failure  to 
detect  appreciable  killing  of PPLO  appears  not  because  of  an  excess  of  the 
organisms  in  the  suspension.  Modification  of the  incubation mixture  by sub- 
stituting medium 199 for MEM failed to uncover myeoplasmacidal activity. 
Jones and Hirsch, in their studies of phagocytosis by mouse peritoneal macro- 
phages of M. pulmonis,  demonstrated ingestion and digestion using 20% heat- MICHAEL  S.  SIMBERKOFF  AND  PETER  ELSBACI:I  1421 
inactivated fetal calf serum (7). As shown in Fig. 4, viable counts of M. hominis 
incubated with human leukocytes were the same at three different human serum 
concentrations. Substitution of heat-inactivated fetal calf serum for the human 
serum in the incubation mixture also did not alter the results. 
Extracts of leukocytes have been shown to possess potent mycoplasmacidal 
activity at low pH towards M. pneumoniae,  M. salivarium  and M. fermentans 
(16), and M. hominis  (17). Fig. 5 shows one of four virtually identical experi- 
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FIG. 3.  Viability of M.  hominls  (PPLO)  incubated  with rabbit granulocytes and  anti- 
serum at varying ratios of organisms to cells (see legend to Fig. 1). Open symbols represent 
aliquots of the whole suspension and  the closed symbols aliquots of supernatant  fluids  pre- 
pared by centrifugation of the suspension at 50 g for 10 min. 
ments in which the effect of incubation with intact or homogenized leukocytes 
on viability of M. hominis  was  compared. It is  evident that whole leukocyte 
homogenates also contain mycoplasmacidal activity towards M. hominis.  The 
lag of 2 hr before killing of mycoplasma became manifest was also observed by 
Dajani and Ayoub (16), when the leukocyte extract was diluted. 
Differences in  apparent potency between the  extracts prepared by Dajani 
and Ayoub and the homogenates used in our experiments probably reflect the 
fact that  we  tested mycoplasmacidal activity at  pH  7.4  (rather  than  at  its 
optimal pH of 4.7 [16]), so that the effect of homogenized cells could be com- 
pared with that of intact cells. 1422  POLYMORI~IIONUCLEAR  LEUKOCYTES  AND  MYCOPLASMA 
Since estimates of the total number of PPLO in the suspensions were based on 
the capacity of the organisms to form colonies, it is conceivable that the actual 
number of mycoplasma particles in a suspension greatly exceeded the number 
of colony-forming units. This did not seem likely since counting of aliquots of 
mycoplasma suspensions under the phase-contrast microscope gave values that 
corresponded to the number of colony-forming units. However, an additional 
measure of uptake of PPLO was deemed necessary. Radioisotopically-labeled 
PPLO were prepared by incubating M.  hominis in rapid  growth phase with 
palmitate-l-14C. This results in extensive labeling of the organisms' phospho- 
lipids. After washing of the labeled PPLO, more than 95 % of the radioactivity 
was in phospholipids and less than 3 % remained as free fatty acid. Incubation 
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FIG. 4.  Viability  of M. hominis (PPLO) incubated with human peripheral blood leuko- 
cytes, antiserum, and normal human serum at the indicated concentrations. 
of the labeled PPLO at two concentrations with rabbit granulocytes revealed 
that practically the same amount of radioactivity remained in the supernatant 
fraction of suspensions of PPLO alone and of PPLO plus granulocytes (Fig. 6), 
confirming the evidence obtained in the preceding experiments on viability. 
At the lower concentration of labeled PPLO it appears that somewhat more 
radioactivity sedimented with the leukocytes after incubation for 2 hr. In four 
additional experiments, carried out for 3 hr, no evidence was obtained that the 
granulocytes sequestered more PPLO at longer time intervals, either at high or 
at low PPLO to leukocyte ratios.  Fractionation of the lipids  extracted from 
suspensions of PPLO  and of PPLO incubated with granulocytes for periods of 
up  to 3  hr,  showed no release of labeled free fatty acid or other breakdown 
products of the PPLO phospholipids. Thus, we obtained no evidence of degrada- 
tion  of PPLO  lipids.  These findings  contrast with  those obtained in  similar 
experiments with  another microorganism  (partially)  devoid of the  cell wall, MICHAEL S.  SIMBERKOFF AND  PETER  ELSBACH  1423 
namely  spheroplasts  prepared  from  palmitate-lJ4C-labeled  E.  coli,  which 
undergoes  rapid  and  extensive  degradation  when  exposed  to  granulocytes 
(unpublished observation). These experiments indicated not only that PPLO is 
not killed to any extent during incubation with leukocytes for 2 hr, but also that 
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FIG. 5.  Viability of M. hominis  (PPLO)  incubated with intact or homogenized  rabbit 
granulocytes and  specific antiserum. 
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t4  FIG. 6.  Lack of removal of palmitate-1-  C-labeled M. hominis by rabbit granulocytes. 
The experiment was carried out as described in the legend of Fig. 1, except that aliquots of the 
whole suspension or of the supernatant fluid obtained after centrifugafion at 50 g for 10 rain 
were extracted for lipids. Labeled PPLO were added in ratios of 100 or 10 organisms to one 
granulocy te. 
no  appreciable  tight  adsorption  onto  the  phagocytic cells  could have  taken 
place. 
Effect of PPLO on Several Metabolic Functions  of Rabbit  and Human  Leuko- 
cytes.--Phagocytosis  of various  types of particles and  microorganisms is  ac- 
companied by marked stimulation of 02  uptake  and formation of 14CO~ from 
glucose-l-14C  (in  this  cell type  a  reasonably  accurate index  of hexose mono- 1424  POLYMORPHONUCLEAR  LEUKOCYTES  AND  MYCOPLASN[A 
phosphate shunt [HMS] activity). Despite the apparent inability of the leuko- 
cytes to remove PPLO from the suspension, ~aCO,, production from glucose-l-14C 
added  to the medium is markedly enhanced  (Fig.  7).  Production  of ~4CO2 by 
granulocytes  incubated  with  PPLO  or  with  polystyrene particles  was  com- 
pared. Polystyrene particles elicited the familiar almost 10-fold stimulation of 
~4CO2 production from glucose-l-sac. In 10 experiments conversion of glucose-1- 
'*C to ~4CO,., by 2  X  107  leukocvtes incubated with polystyrene amounted  to 
100  =t=  16 nmoles (mean ::k  SEM) in 30 rain.  Comparable stimulation was seen 
when PPLO in the presence of antiserum in a ratio of 10 organisms: 1 granulo- 
cvte were added to the suspension. An even greater stimulation occurred when 
the ratio was 100:1.  In the absence of antiserum the stimulation was approxi- 
mately half of that  observed in its presence. Appropriate controls showed no 
~C02 production from glucose-l-z4C by M. hominis or M. arlhrilidis incubated 
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Fro. 7.  Production of 14CO2 from glucose-l-14C by rabbit granulocytes. The results are 
expressed as per cent of the I4CO2 produced by rabbit granulocytes incubated  with poly- 
styrene beads for 30 min. M. arthritidls (PPLO) and specific antiserum were added as indi- 
cated. 
in the absence of polymorphonuclear leukocytes. Antiserum alone had no effect 
on  14CO2 production  by  leukocytes.  Aerobic  glycolysis,  as  measured  by  the 
conversion of glucose-6-14C  to 14CO2, was modestly stimulated by polystyrene 
particles,  but  did  not  increase  when  mycoplasma was  added  (not  shown), 
excluding  the  possibility  of  a  nonspecific  stimulation  of  glucose  metabolism 
through increased entry of glucose because of a change in permeability. 
The  effect  of  various  antisera  on  14CO2 production  from glucose-lJ4C  by 
granulocytes  incubated  with  either M.  hominis  or M.  arlhritidis  is  shown in 
Table I. The antisera were species specific in their capacity to inhibit  growth 
of  mycoplasma. While  heterologous  antisera  enhanced  14CO.2 production  by 
granulocytes in the presence of PPLO, type-specific antisera, even when diluted, 
were consistently more stimulatory. Heat-inactivated PPLO evoked the same 
antiserum-dependent metabolic response as live organisms (Table II). 
Previous studies in our laboratory have indicated that phagocytosis of poly- 
styrene particles by granulocytes is associated with a marked stimulation of the MICHAEL  S.  SIMBERKOFF  AND  PETER  ELSBACI-I  1425 
conversion of medium  lysolecithin to cellular lecithin (15,  18). This stimulation 
of acylation of the lysocompound  is not observed in presence of PPLO  (Table 
III).  Further,  acylation is less when both polystyrene particles  and PPLO  are 
present than with polystyrene particles alone. 
TABLE  I 
Effect of Specific and Nonspecific Antiserum  on Stimulation  of 14C02 from Glucose-l-14C by 
Rabbit Granulocytes Incubated with PPLO 
M.  arthritidis  M.  hominis 
Incubation  (min)  15  30  15  30 
nmoles 
Normal rabbit serum  8  15  20  49 
Anti-M. arthritidis  47  110  48  85 
Anti-M. hominis undiluted  --  --  68  105 
Anti-M. hominis  1:10  --  --  69  122 
Anfi-M. hominis 1:100  --  --  34  81 
Anti-M. salivarium  18  39  40  90 
Anti-M. neurolyticum  18  33  36  78 
The experiment was carried out as described in Materials and Methods. Mycoplasma was 
added in a ratio of 100 organisms to 1 granulocyte. All sera, undiluted or diluted as indicated 
were added in an amount of  10 M/reaction mixture of 0.5 ml. Results are given as nmoles 
of glucose oxidized. 
TABLE  II 
Comparison of Effect of Live and Heat-Killed PPLO on  14C02 Production from Glucose-l-14C 
by Granulocytes 
Incubation  (min)  15  30 
nmoles 
Live PPLO  +  NRS*  8  16 
Live PPLO  +  antiserum  41  81 
Dead PPLO  +  NRS*  9  18 
Dead PPLO +  antiserum  43  87 
Comparison of  the effect of  live and heat-killed M.  hominis on  14COz production from 
glucose-l-14C by rabbit granulocytes. The experiment was carried out as described in Mate- 
rials and Methods and in the legend of Table I. M. hominis or heat-killed M. homlnis were 
added to the granulocytes in a ratio of 100 organisms to 1 granulocyte. Normal rabbit serum 
or specific antiserum were added in an amount of 10 tA/incubafion flask. 
* NRS, normal rabbit serum. 
Effect of PPLO  on  the Killing  of E.  coli by Granulocytes.--The  findings  de- 
scribed  so far  suggested  that  PPLO  induces  alterations in  leukocyte  function 
without  being ingested  to  any  great  extent.  In  the following  experiments  we 
examined  the possibility that PPLO  affected the granulocyte's ability to carry 
out phagocytosis of other microorganisms. The effect of PPLO  added at various 1426  POLYMORPHONUCLEAR  LEUKOCYTES  AND  IVI¥COPLASN[A 
TABLE  III 
Lecithin Synthesis from Lysolecithin-3~P  by Granulocytes  Incubated with or Without PPLO in 
lhe Presence or Absence of Polystyrene Particles 
Incubation time 
Granulocytes -  PPLO  Granulocytes Jr- PPLO 
-- Polyst.  l- Polyst.  -- Polyst.  Jr Polyst. 
min 
15  33.5  4-  3.7  61.8  -4-  2.0  35.3  4-  2.9  45.9  4-  3.9 
30  58.3  4-  3.8  100  53.5  4-  2.5  73.6  4-  5.9 
Incorporation of  lysolecithin-~2P complexed  to  albumin  into  granulocyte  lecithin  was 
determined as described in Materials and  Methods and elsewhere (18). 
Results  of  five experiments,  carried  out  in  duplicate,  was  given as  per  cent  (mean  4- 
standard error of the mean)  of the value for  lecithin synthesis at 30 min. The differences 
between lecithin synthesis by granulocytes incubated with polystyrene beads in  the absence 
and presence of PPLO were statistically  significant.  (At 15 min P  <  0.005  and at 30 rain 
P  <  0.02).  Suspensions of PPLO did not convert lysolecithin to lecithin. 
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FIG.  8.  Effect of preincubation of human leukocytes with M.  hominis  on bactericidal 
activity  against E.  coli.  Leukocytes,  M.  hominis  (100  organisms/leukocyte),  and  specific 
antiserum were incubated for the indicated periods of time before E. toll were added to the 
mixtures.  Individual points represent viable counts of E.  coli derived from aliquots of  the 
suspensions taken at the indicated times of incubation. 
times before addition of E. coli on bacterial killing by granulocytes is shown in 
Fig.  8.  Preincubation  of  the granulocytes  with PPLO  for 30 or 60 min results 
in marked  impairment  of bacterial killing.  When  PPLO  and E.  coli,  both in a 
ratio of 100 microorganisms: 1 granulocyte,  are added simultaneously, killing of 
E. coil was usually only little inhibited, suggesting that any effect of PPLO  on MICHAEL  S.  SIMBERKOFF  AND  PETER  ELSBACH  1427 
the leukocyte's bactericidal activity was not simply because of dilution of E. 
coil as ingestible material. 
Fig.  9  depicts  the protective effect of PPLO  against  killing  of E.  coli  by 
granulocytes, as a function of the number of E. coli in the suspension. The fewer 
the E. coli the more dramatic the inhibition of killing. 
DISCUSSION 
The findings we have presented here indicate that two species of mycoplasma, 
M. hominis and M. arthritidis,  are not effectively ingested and killed by human 
and rabbit leukocytes under conditions that permit the rapid phagocytosis of 
E.  coli.  The main evidence for this conclusion rests on studies of viability of 
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FIO.  9.  Effect of preincubation of human leukocytes with M. hominis  (100  organisms/ 
leukocyte)  for 30 rain on subsequent killing of E. coli added at various ratios of bacteria to 
leukocytes. Incubation was carried out as described in the legend of Fig. 8. The bars represent 
the per cent of the viable E. coli count at time 0 (mean of duplicate determinations). 
PPLO  incubated with  granulocytes,  as  well  as  on  experiments with  labeled 
PPLO. The latter  showed in addition  that  PPLO apparently do not  tightly 
adhere  to  the  leukocytes since little  or no  radioactive  material  sedimented 
with the phagocytes. This finding is surprising because it contrasts with morpho- 
logical observations by others that indicate a striking tendency on the part of 
PPLO to adhere to surfaces of mammalian cells (5-7)  including polymorpho- 
nuclear  leukocytes  (5).  However, neither  the  tightness  of  binding,  nor  the 
ability of the species of mycoplasma used in our studies to adhere to cells other 
than leukocytes, has been examined to our knowledge. 
Further evidence that mycoplasma is not readily engulfed by granulocytes, 
even  in  the  presence  of  species-specific antiserum,  is  provided by  electron- 
microscopic  observations  2 (not  shown),  that  revealed only rare intracellular 
PPLO at a ratio of 10:1, and few intracellular organisms at a ratio of 100 PPLO: 
1 granulocyte. 
2 We are indebted to Dr. D. Zucker-Franklin who performed the electron microscopy. 1428  POLYMORPHONUCLEAR LEUKOCYTES  AND  MYCOPLASMA 
Even though few mycoplasmas could be demonstrated intracellularly in these 
experiments, stimulation of '4CO~ production from glucose-l-14C  was at least as 
great after addition of PPLO as in the presence of polystyrene particles (thin 
sections of such granulocytes contained from 15  to 25 latex particles). It ap- 
pears less  likely that this metabolic response is because of occasional ingested 
mycoplasmas,  since  up  to  10-fold  stimulation  of 14CO2 production was  seen 
under circumstances where virtually no intracellular PPLO were seen. However, 
stimulation of I~CO2 production by granulocytes in the absence of phagocytosis 
can be demonstrated in response to numerous chemical and  biological agents 
(19-22).  Most  of these have detergent properties and affect the cell surface. 
We propose therefore that the effect of PPLO on granulocyte metabolism re- 
flects a perturbation of the cell surface and quite possibly damage to the cells. 
Support for this hypothesis may be found in the inhibitory effects of PPLO on 
killing of E. coli and on the stimulation of acylation of lysolecithin that normally 
accompanies phagocytosis of polystyrene and other particles (15,  18). The con- 
cept that mycoplasma may cause cell damage,  especially in conjunction with 
antibody and complement, has been put forth previously (23). 
The strikingly different results of our studies on granulocytes and of those 
of Jones and Hirsch (7)  on peritoneal macrophages may perhaps be explained 
in this context. Jones and Hirsch found specific antiserum-dependent ingestion 
and digestion of M. pulmonis by mouse peritoneal macrophages in culture. The 
ability of the macrophages but not of cultured fibroblasts to engulf adherent 
M. pulmonis  was triggered within minutes after addition of anti-mycoplasma 
antibody and exhibited all the morphological characteristics of effective phago- 
cytosis. It is possible that differences in the origins of the cells and in incuba- 
tion  procedure  account  for  the  different  behavior  of  the  rabbit  or  human 
granulocytes and the mouse macrophages. On the other hand, our experiments 
were carried out under conditions that permit rapid phagocytosis and killing 
oi a  Mde variety of microorganisms. It seems more likely therefore that  the 
apparent  inability of the granulocyte to ingest M. hominis  or M.  arthrilidis 
in vitro represents a specific feature of this type of phagocyte. For example, it 
is  conceivable that  the granulocyte possesses a  sensitivity to mycoplasma or 
its product(s) that distinguishes this phagocyte from others. 
While our data seem consistent with  a  damaging  effect of mycoplasma on 
the leukocytes, the manner in which this action is exerted remains to be deter- 
mined.  In  preliminary experiments we have noted  that  medium  (MEM)  in 
which  PPLO had been incubated for varying periods of time before removal 
of the organism by sedimentation at 20,000 g for 20 rain affects ~4CO2 produc- 
tion by granulocytes. This finding suggests release of substance(s)  that modify 
the granulocyte's membranes and/or metabolism. However, thus far effects of 
medium prepared in this manner have been variable and at no time as marked 
as  those  of whole  PPLO  suspensions.  Another  aspect  that  requires  further MICHAEL  S.  SIMBERKOFP  AND  PETER  ELSBACH  1429 
study is the effect of PPLO on phagocytosis and killing of microorganisms other 
than E. coli. Although viability of E. coli alone is not altered by PPLO under 
the  conditions  of  these  experiments,  diminished  bactericidal  activity of  the 
leukocytes might be because of an effect on the organism rather than on the 
phagocyte. Such effects might differ with different microbial species. 
SUMMARY 
The interaction between mycoplasma (PPLO)  and human or rabbit louko- 
cytes was examined in vitro. 
Upon incubation of M. hominis or M. arthritidis for 2 hr with rabbit peritoneal 
exudate granulocytes or leukocytes from human peripheral blood, no killing of 
mycoplasma was  observed either in  the presence or  absence of type-specific 
antiserum.  However, 14CO2 production from glucose-l-14C  was  stimulated  up 
to 10-fold in the presence of live or heat-killed PPLO. The extent of stimulation 
depended  upon  the  number  of  organisms  and  the  presence  of  type-specific 
antiserum.  The  stimulation  of 14CO2 production  seems  not  because  of  tight 
adherence  of  PPLO  to  the  leukocytes,  since  PPLO  were  quantitatively  re- 
covered in the medium after sedimenting the granulocytes. 
The  enhanced  conversion of medium  lysolecithin  to  cellular  lecithin  that 
accompanies phagocytosis of polystyrene particles  was  significantly  reduced 
when PPLO were also present. Mycoplasma alone elicited no stimulation  of 
lecithin formation. 
Killing of E. toll,  a microorganism readily engulfed and killed by leukocytes 
in vitro, was  diminished when the leukocytes were preincubated with  myco- 
plasma. 
These findings indicate that M.  hominis and M.  arthritidis  are not ingested 
by granulocytes to any detectable extent, but that these organisms affect the 
leukocytes' metabolism and also impair phagocytosis of E. coll. 
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